1. Home
  2. AFMD vs WKHS Comparison

AFMD vs WKHS Comparison

Compare AFMD & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • WKHS
  • Stock Information
  • Founded
  • AFMD 2000
  • WKHS 2007
  • Country
  • AFMD Germany
  • WKHS United States
  • Employees
  • AFMD N/A
  • WKHS N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • AFMD Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • AFMD Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • AFMD 45.6M
  • WKHS 44.3M
  • IPO Year
  • AFMD 2014
  • WKHS N/A
  • Fundamental
  • Price
  • AFMD $1.27
  • WKHS $0.82
  • Analyst Decision
  • AFMD Strong Buy
  • WKHS Sell
  • Analyst Count
  • AFMD 5
  • WKHS 3
  • Target Price
  • AFMD $13.50
  • WKHS $5.75
  • AVG Volume (30 Days)
  • AFMD 498.2K
  • WKHS 2.7M
  • Earning Date
  • AFMD 11-14-2024
  • WKHS 11-19-2024
  • Dividend Yield
  • AFMD N/A
  • WKHS N/A
  • EPS Growth
  • AFMD N/A
  • WKHS N/A
  • EPS
  • AFMD N/A
  • WKHS N/A
  • Revenue
  • AFMD $6,287,085.00
  • WKHS $9,097,780.00
  • Revenue This Year
  • AFMD N/A
  • WKHS N/A
  • Revenue Next Year
  • AFMD $28.44
  • WKHS $247.90
  • P/E Ratio
  • AFMD N/A
  • WKHS N/A
  • Revenue Growth
  • AFMD N/A
  • WKHS N/A
  • 52 Week Low
  • AFMD $1.40
  • WKHS $0.57
  • 52 Week High
  • AFMD $8.95
  • WKHS $8.18
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 16.00
  • WKHS 38.91
  • Support Level
  • AFMD $1.40
  • WKHS $0.99
  • Resistance Level
  • AFMD $2.21
  • WKHS $1.26
  • Average True Range (ATR)
  • AFMD 0.24
  • WKHS 0.09
  • MACD
  • AFMD -0.08
  • WKHS -0.03
  • Stochastic Oscillator
  • AFMD 3.33
  • WKHS 3.09

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: